Nebenwirkungen · Abiraterone Mylan
Abiraterone Mylan 500 mg film-coated tablets Abiraterone Mylan 1000 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 8–9
HOS-146789 · Präparat HOS-099564
8 General disorders and administration site very common: oedema peripheral conditions Injury, poisoning and procedural common: fractures** complications * Cardiac failure also includes congestive heart failure, left ventricular dysfunction and ejection fraction decreased. ** Fractures includes osteoporosis and all fractures with the exception of pathological fractures a Spontaneous reports from post-marketing experience b Alanine aminotransferase increased and/or aspartate aminotransferase increased includes ALT increased, AST increased, and hepatic function abnormal.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-01-19T13:57:00Z · SHA-256 a224b8fadc2ad3e1b1af874d8687b8e3d6bb14c5f714b2308f5ba81c1b78da11 · Passage 1693e642e61daac12ec3402aa9910dfe8eb70a7e04f3e5cac1c48a3868c6e94d · Zeichen 4249–4894 im Abschnitt